Cognitive impairment as a target for pharmacological treatment in schizophrenia
- 1 September 1995
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 17 (1) , 123-129
- https://doi.org/10.1016/0920-9964(95)00037-m
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The cost of cognitive impairment in schizophreniaSchizophrenia Research, 1995
- Cortical cholinergic markers in schizophreniaSchizophrenia Research, 1994
- 11. Neuropsychological deficits in the early course of first episode schizophreniaSchizophrenia Research, 1991
- The neuropsychology of schizophreniaBehavioral and Brain Sciences, 1991
- Neuroleptic drug effects on cognitive function in schizophreniaSchizophrenia Research, 1990
- The effects of neuroleptics on neuropsychological test results of schizophrenicsArchives of Clinical Neuropsychology, 1988
- Schizophrenic syndromes, cognitive performance and neurological dysfunctionPsychological Medicine, 1987
- Global attentional deviance as a marker of risk for schizophrenia: Specificity and predictive validity.Journal of Abnormal Psychology, 1985
- Neuropsychological performance and positive and negative symptoms in schizophrenia.Journal of Abnormal Psychology, 1985
- The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test.Journal of Consulting Psychology, 1951